Karpas Strategies, LLC Viatris Inc Transaction History

Karpas Strategies, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$9.59 - $11.35 $709 - $839	-74 Reduced 0.68%	10,768 $106,000
Q2 2023 Aug 10, 2023	BUY	$9.02 - $10.29 $748 - $854	83 Added 0.77%	10,842 $108,000
Q1 2023 May 02, 2023	BUY	$9.2 - $12.26 $377 - $502	41 Added 0.38%	10,759 $103,000
Q4 2022 Feb 07, 2023	SELL	$8.72 - $11.56 $9,382 - $12,438	-1,076 Reduced 9.12%	10,718 $119,000
Q3 2022 Oct 28, 2022	BUY	$8.48 - $11.13 $805 - $1,057	95 Added 0.81%	11,794 $100,000
Q2 2022 Jul 19, 2022	BUY	$9.95 - $12.27 $815 - $1,006	82 Added 0.71%	11,699 $122,000
Q1 2022 Apr 19, 2022	BUY	$9.81 - $15.4 $804 - $1,262	82 Added 0.71%	11,617 $126,000
Q2 2021 Jul 28, 2021	SELL	$12.97 - $16.15 $18,793 - $23,401	-1,449 Reduced 11.16%	11,535 $165,000
Q1 2021 May 05, 2021	SELL	$13.59 - $18.54 $584 - $797	-43 Reduced 0.33%	12,984 $181,000
Q4 2020 Jan 27, 2021	BUY	$14.3 - $18.74 $186,286 - $244,125	13,027 New	13,027 $244,000

1,136

989M

2.34M

2.21M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $9.18B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Karpas Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Karpas Strategies, LLC with notifications on news.